Advance in the treatment of glioma by neural stem cells / 药学学报
Acta Pharmaceutica Sinica
; (12): 510-516, 2017.
Article
ي Zh
| WPRIM
| ID: wpr-779622
المكتبة المسؤولة:
WPRO
ABSTRACT
Neural stem cells (NSCs) posse the specialty of tumor tropism and be able to migrate specifically to tumor cells. NSCs are also cross the blood brain barrier. NSCs keep in touch with tumor cells preferentially under the tumor microenvironment, and surround the target cells. Based on these characteristics, NSCs can be used as a carrier for therapeutic virus, enzymes/prodrugs, genes or suicide genes, etc. which are selectively delivered to the glioma cells. NSCs may be modified by a variety of different genes to establish a reliable, safe and effective therapy for glioma.
النص الكامل:
1
الفهرس:
WPRIM
اللغة:
Zh
مجلة:
Acta Pharmaceutica Sinica
السنة:
2017
نوع:
Article